SiS.net3, the International network of National Contact Points in the field of Science with and for Society in Horizon 2020 are organising the brokerage event on 17th-19th March, 2020 in Brussels. The event will be of particular interest and relevance to members of...
COMING SOON. RESTORE Momentum Workshop, 17th February 2020, Berlin
On 17th February 2020 the RESTORE Momentum Workshop will take place in Berlin and will welcome RESTORE supporters and partners. TEDDY Network is involved in RESTORE as supporter, a large-scale Research Initiative with the scope to create a consortium aimed to build a...
COMING SOON. DIA Europe 2020, 17th-19th March 2020, Brussels
DIA (Drug Information Association) bring together its members to collaborate on and discuss global and local challenges facing the life sciences field in an increasingly more complex and interconnected world. DIA Europe 2020 is the largest and most forward-looking...
Clinical Trials Europe, 20th November 2019: TEDDY efforts to promote patient’s engagement were presented
On 19th and 20th November 2019, the Annual meeting “Clinical Trials Europe” was held in Barcelona and provided the occasion to bring the clinical community together. The participants had the possibility to share and discuss fresh perspectives and practises for...
A new year of activities for KIDS Bari and KIDS Albania has started
We are happy to announce that even this year the youths of KIDS Bari and KIDS Albania have kicked off their activities aimed to promote the involvement of young persons and patients in the research and clinical fields strongly favouring the achievement of goals in the...
Vincristine shortage: an overview on the current European situation
Over the last months, a worrying shortage in the production and distribution of vincristine has affected the health marketplace across the world. Vincristine is an antineoplastic drug, a natural extract from the periwinkle (Cantharanthus roseus, formerly Vinca rosea),...
FDA approves voxelotor for sickle cell disease
On November 25th, 2019, the Food and Drug Administration (FDA) granted accelerated approval to voxelotor (Oxbryta, Global Blood Therapeutics) for adults and paediatric patients 12 years of age older with sickle cell disease (SCD). SCD is a lifelong inherited blood...
Publication: “Survey by TEDDY European Network of Excellence for Paediatric Clinical Research demonstrates potential for Europe‐wide trials”
Ensuring high-quality ethical research on the safety and efficacy of medicines for children represents one of the main objectives of the paediatric sector! However, there are no summary data in the public domain about the capacity and competence of European paediatric...
TEDDY Network was presented at the EUCROF Training Day on “Essentials of Paediatric Clinical Research
On 24 October 2019, EUCROF Paediatric Working Group organised a F2F training on “Essentials of paediatric clinical research” held at the Centro Nacional de Invesigaciones Oncológicas in Madrid. The meeting provided the occasion to give an overview of the current...
SAVE THE DATE: 4th EPTRI General Assembly Meeting, 21 and 22 October 2019 in Warsaw, Poland
On 21 and 22 October 2019, the 4th EPTRI General Assembly Meeting will be held in Warsaw and will be organised in collaboration with the Polish partner, the Children’s Memorial Health Institute. EPTRI (European Paediatric Translational Research Infrastructure) is...